Clinical Trials
Thoracic surgery clinical trials are pivotal in advancing treatments for diseases affecting the chest, such as lung cancer, esophageal cancer, and a number of benign diseases. These trials often explore innovative surgical techniques, new drug therapies, quality improvement, and combinations of treatments to improve patient outcomes. We are continually seeking access to both peer-review and industry funding to support our research.
Currently Open Clinical Trials
Postoperative Digital Care Home Monitoring. (P.I. Dr. Richard Malthaner)
Patient Reported Outcomes Targeting Early Chest Tube Removal Study. (P.I. Dr. Rahul Nayak)
Prevention of Post Operative Urinary Retention in Thoracic Surgery. (P.I. Dr. Rahul Nayak)
Nutritional support in patients undergoing induction therapy for esophageal cancer: a feasibility randomized controlled trial. (P.I. Dr. Mehdi Qiabi)
The use of multi-modal radiomics as a clinical predictor for early-stage esophageal cancer. (P.I. Dr. Mehdi Qiabi)
A Randomized Phase III Study of Sublobar Resection Versus Stereotactic Ablative Radiotherapy in High Risk Patients with Stage I Non-Small Cell Lung Cancer. (P.I. Dr. Richard Malthaner)
